Navigation Links
Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
Date:5/15/2008

WOODCLIFF LAKE, N.J., May 15 /PRNewswire/ -- Eisai Corporation of North America announced today that results from 16 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago from May 30 to June 3, 2008.

A wide variety of abstracts on Eisai marketed products and investigational compounds will showcase research focused on metastatic breast cancer, lung cancer, ovarian cancer, brain cancer, mesothelioma, pancreatic cancer, myelodysplastic syndromes and other types of cancer, as well as supportive care to aid those currently undergoing treatment for cancer.

"Eisai's commitment to oncology is clearly translating into the substantial growth of our pipeline," said Haruo Naito, President and CEO, Eisai Co., Ltd. "Eisai's focus on becoming a global leader in oncology reflects our human health care mission to satisfy unmet medical needs and increase benefits to patients and their families."

The following Eisai abstracts are accepted for presentation at this year's ASCO meeting.

Product Abstract Details Location Details

MORAb-003 Exploratory Phase II Efficacy June 1, 2008

(farletuzumab) Study of MORAb-003, a Monoclonal 4:30-4:45 p.m.

Abstract No: 5500 Antibody against Folate Receptor Location: S406

Alpha, in Platinum-Sensitive (Vista Room)

Ovarian Cancer in First Relapse

Oral Presentation

E7080 A phase I study of E7080 in May 31, 2008

Abstract No: 3526 patients with advanced 8:00 a.m.

malignancies -12:00 p.m.


'/>"/>

SOURCE Eisai Corporation of North America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GeoVax Secures $10 Million Financing Commitment
2. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
3. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
4. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
5. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
6. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
7. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
10. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
11. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... and CAESAREA, Israel , May 22, ... New clinical data presented from the DEFLECT-I study demonstrates ... reduces brain lesion volume during TAVR (Transcatheter Aortic Valve ... Keystone Heart Scientific Advisory Board announces consensus on the ... regarding the importance and need for cerebral protection during ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
(Date:5/23/2013)... Heights,OH (PRWEB) May 23, 2013 Angeline Jolie’s ... genetic study showing there was an 87% chance she would ... odds of getting breast cancer. Long term studies show American ... during their lifetime (1). , Among the things that ... alcohol (more than a drink a day) smoking, and avoiding ...
(Date:5/23/2013)... According to the Centers for Disease Control, heart ... America today and is the leading cause of death in ... in the United States each year of heart disease, translating ... to profile the status of the cardiovascular system, with cholesterol ... the false assumption that if cholesterol levels are good, this ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 US ... 5.1 percent annually to $8.0 billion in 2017. ... the increasing need for high-performance plastic films that ... and chemical resistance in packaging and construction applications. ... market areas such as photovoltaic modules biodegradable products, ...
(Date:5/23/2013)... 23, 2013 Dr. Garber's Natural ... specific remedies are now available at Whole Foods Laguna ... 92677. The line of natural biotherapy formulas continues to ... , Represented by Brandstorm HBC (Los Angeles, CA), the ... throughout California, Nevada and Arizona, as well as Lassen's ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Spring is ... Assisi Veterinary Hospital urges pet owners to be aware of ... treatments for pet allergies. , An allergy is a state ... called an allergen. Allergen exposure may cause an over-reaction. This ... against infection and disease, can actually be harmful to the ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie has Women Asking for Ways to Reduce the Risk of Breast Cancer 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 2Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 4Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Allergy Season Affects Pets as Well as People 2
... sympathetic to people suffering from the same misfortune as a ... generally more sympathetic, according to the authors of a new ... A. Small and Uri Simonsohn (both University of Pennsylvania) seek ... become more sympathetic when a friend or loved one falls ...
... into the desire to have an attractive smile is ... immigrants are the most receptive to oral health messages, ... of Consumer Research . , Authors Shuili Du ... and C.B. Bhattacharya (Boston University) evaluated the effectiveness of ...
... The American Academy of Actuaries, Public Interest Committee ... market value of assets and liabilities for ... use information obtained through this forum ... board of directors on the issue is appropriately in the public ...
... 22 Republican National,Committee (RNC) Chairman Robert M. ... http://www.newscom.com/cgi-bin/prnh/20080519/RNCLOGO ), "While Barack Obama ... political tactics to push poor people away from ... is yet another example of,Obama,s rhetoric not matching ...
... --, NEW YORK, Aug. 22 The Guardian ... has hired industry veteran,Dale Magner to its leadership team. ... plan sales and distribution to his new post as,Vice ... August 12., Magner will be responsible for developing ...
... ST. LOUIS, Aug. 22 CMS, Inc., an ... and workflow management,solutions, has received FDA 510(k) clearance ... allows CMS to immediately,begin distributing Atlas-Based Autosegmentation for ... the amount of time spent creating and editing,patient ...
Cached Medicine News:Health News:Charities take note: Personal relationships increase donations 2Health News:A reason to smile: New immigrants respond best to oral hygiene campaign 2Health News:Actuaries to Host Forum on Public Pension Disclosures 2Health News:Actuaries to Host Forum on Public Pension Disclosures 3Health News:RNC Statement Obama and Health Care 2Health News:Dale Magner Joins Guardian as Vice President 2Health News:CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: